We are are happy to announce we are sponsoring this year's Meeting on the Med event on the 12th-14th of April in Barcelona!
We are proud sponsors of this year's Meeting on the Med event in Barcelona, Spain!
The Cell & Gene Meeting on the Med is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space.
We are also participating in the agenda. You can come and see us at the following:
PLENARY SESSION: A NEW ERA FOR ATMPS – COMMERCIALIZING IN THE EU {BioCentriq Ballroom} at 9:15am – 10:15am on the 12th of April:
Speakers:
- Matthew Durdy, Chief Executive Officer, Cell and Gene Therapy Catapult
- Lutz Bonacker, Ph.D., Senior Vice President and General Manager, Commercial Operations Europe, CSL Behring
- Emmanuel Chantelot, Vice President, Head of International Policy and Government Affairs, Bristol-Myers Squibb
- Chris Fox, President, Novartis Gene Therapies
If you would like to schedule a meeting with a member of the team at this event, please email comms@ct.catapult.org.uk